WHO last week stopped one arm of the Covid-19 Solidarity trial of HCQ, only to resume it again this week. Its decision to stop the trial was based on a Lancet study by professor Mandeep Mehra of Harvard and the Brigham and Women’s hospital, who used data from 96,000 patients to conclude that the drug caused higher mortality in its trial patients.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/30eeSkW
via IFTTT
0 comments:
Post a Comment